Three Year Follow up of a Randomised Controlled Trial (RCT) of an Intervention for Tobacco Dependence Among Those With a Psychotic Illness

This study has been completed.
Sponsor:
Collaborator:
Australian Government Department of Health and Ageing
Information provided by:
The University of New South Wales
ClinicalTrials.gov Identifier:
NCT00350493
First received: July 6, 2006
Last updated: September 25, 2008
Last verified: September 2008
  Purpose

This is a three year follow up of a previous study where researchers at UNSW and UNewc asked smokers with serious mental health problems to participate in a 12-month study, to assess whether intervention could assist people experiencing mental illness reduce their tobacco smoking.


Condition Phase
Psychotic Disorder
Behavior, Addictive
Phase 4

Study Type: Observational
Official Title: Three Year Follow up of a Randomised Controlled Trial of an Intervention for Tobacco Dependence Among Those With a Psychotic Illness

Resource links provided by NLM:


Further study details as provided by The University of New South Wales:

Estimated Enrollment: 298
Study Start Date: January 2005
Study Completion Date: February 2006
Primary Completion Date: February 2006 (Final data collection date for primary outcome measure)
Detailed Description:

Between 2001 and 2003, the School of Public Health and Community Medicine at the University of New South Wales carried out a large study with the Centre for Mental Health Studies at the University of Newcastle. The project asked people with serious mental health problems, who also smoked cigarettes, to participate in a 12-month study, which involved completing several questionnaires/other assessments over that time with a member of the research team. Around half of the participants in this study also received treatment for their smoking from the research team. This treatment involved weekly therapy with one member of the research team, and covered the relationship between smoking and mental illness, teaching people to cope with desires to smoke, how to recognise and avoid high risk situations for smoking, and how to plan alternative ways of coping with those situations where smoking usually occurred. In addition, nicotine patches were also available to assist people who made the decision to reduce their smoking. This study hoped to learn whether this new treatment could assist people experiencing mental illness reduce their tobacco smoking.

After three years, previous participants were invited to participate in another follow-up assessment to check-in with their current situation, their mental health and levels of smoking.

  Eligibility

Ages Eligible for Study:   18 Years to 67 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Previous participants from the original study
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00350493

Locations
Australia, New South Wales
Centre for Mental Health Studies, University of Newcastle
Newcastle, New South Wales, Australia, 2308
School of Public Health and Community Medicine, University of New South Wales
Sydney, New South Wales, Australia, 2052
Sponsors and Collaborators
The University of New South Wales
Australian Government Department of Health and Ageing
Investigators
Principal Investigator: Robyn Richmond, Professor University of New South Wales
Principal Investigator: Amanda Baker, Assoc Prof Newcastle University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00350493     History of Changes
Other Study ID Numbers: 3Yr FollowUp
Study First Received: July 6, 2006
Last Updated: September 25, 2008
Health Authority: Australia: Department of Health and Ageing Therapeutic Goods Administration

Additional relevant MeSH terms:
Psychotic Disorders
Mental Disorders
Tobacco Use Disorder
Behavior, Addictive
Schizophrenia and Disorders with Psychotic Features
Substance-Related Disorders
Compulsive Behavior
Impulsive Behavior

ClinicalTrials.gov processed this record on July 24, 2014